IAN MORTIMER

Ian Mortimer has served as President and Chief Executive Officer of Xenon Pharmaceuticals since June 2021, previously joining the company as its Chief Financial Officer in 2013. Prior to Xenon, Ian served as Executive Vice President and Chief Financial Officer at Tekmira Pharmaceuticals Corporation (now Arbutus Biopharma Corporation), a Nasdaq-listed biotechnology company, from 2007 until 2013. Ian was responsible for all aspects of Tekmira’s finance and capital markets activities and led its listing on Nasdaq in 2010. From 2004 to 2007, Ian was Chief Financial Officer at Inex Pharmaceuticals and held various other positions from 1997 to 2004.

Since July 2020, Ian has served on the board of directors of Perimeter Medical Imaging AI, Inc., a publicly traded medical device company focused on advanced medical imaging and artificial intelligence tools. Ian has an M.B.A. from Queen’s University, a B.Sc. in Microbiology from the University of British Columbia and is a Chartered Professional Accountant, Certified Management Accountant.